Transplant Diagnostics Market Trends, Growth, Size, Segmentation, Future Demands, Latest Innovation, Regional Forecast to 2028
According to our new research study on “Transplant Diagnostics Market Forecast to 2027 – Global Analysis – by Product & Services, Type, Technology, Application and Geography,” the global transplant diagnostics market size is expected to reach US$ 1,542.89 million by 2027 from US$ 789.88 million in 2018; it is estimated to grow at a CAGR of 7.9% during 2019–2027. The report highlights trends prevailing in the market and factors driving its growth. The transplant diagnostics market growth is attributed to rising need for organ transplantation and rising cell-based research activities. However, the limited number of donors for organ transplantation surgeries may hinder the growth of market.
North America is the largest market
for transplant diagnostics with the US holding the largest market share
followed by Canada. The market for transplant diagnostics in the US is expected
to grow owing to the availability of advanced healthcare infrastructure,
increasing number of transplant procedures as well as availability of skilled
professionals. There has been a substantial increase in the number of
transplant procedures conducted across the US. As per data published by US
Department of Health & Human Services, there were around 36,527 organ
transplants performed in the US in 2018. The country held an annual record for
the sixth consecutive year, as per the Organ Procurement and Transplantation
Network (OPTN). The rise in the number of organ transplant procedures along with
the awareness regarding the importance of organ donation is expected to fuel
growth of the market in the US during the forecast period.
Download the Free PDF Sample Here:
https://www.theinsightpartners.com/sample/TIPRE00003076/
The global transplant diagnostics
market, based on product & services, is segmented into instruments,
reagents & consumables and software & services. The reagents &
consumables segment was the largest among the product & services
subsegments in the transplant diagnostics market in 2018. However, the software
& services segment is expected to witness growth in its demand at the
fastest CAGR of 9.6% during 2019–2027. The global transplant diagnostics
market, based on type, is segmented into solid organ transplantation, soft
tissue transplantation, and stem cell transplantation. The solid organ
transplantation segment held the largest share of the transplant diagnostics
market in 2018 and is anticipated to continue to hold the largest market during
the forecast period. The global transplant diagnostics market, based on
technology, is segmented into molecular assays and non-molecular assays. In
2018, the molecular assays systems segment held a larger share of the market
and is expected to witness growth in its demand at a faster CAGR of 9.5% during
2019–2027. The global transplant diagnostics market, based on application, is
segmented into diagnostic applications and research applications. In 2018, the
diagnostic applications segment held a larger share of the market and is
expected to grow at a faster rate during 2019–2027.
Rising Need
for the Organ Transplantation Fueling Transplant Diagnostics Market Growth
The organ transplantation surgeries
are rising across the world. For instance, in Spain, approximately 5,260
transplant surgeries were performed, among which nearly 3,200 were kidney
transplants and around 1,200 were liver transplant surgeries. The number of
heart transplant surgeries were approximately 300 and lung were nearly 360. The
public–private partnership in assistance with the transplant coordinators has
enormously contributed to the improvement of organ transplantation. The
developing and developed countries have shown significant number of organ transplantation
surgeries. For instance, developing countries such as India and Singapore are
emerging as medical tourism destinations in Asia Pacific. The countries are
growing in terms of offering better and advanced medical treatments.
Transplant
Diagnostics Market: Segmental Overview
Product and
Services-Based Insights
The global transplant diagnostics
market, based on product and services, is segmented into instruments, reagents
& consumables, and software & services. The reagents & consumables
segment held the largest share of the transplant diagnostics market in 2018.
However, the software & services segment is expected to witness growth in
its demand at the fastest CAGR of 9.6% during 2019–2027.
Type-Based
Insights
The global transplant diagnostics
market, based on type, is segmented into solid organ transplantation, soft
tissue transplantation, and stem cell transplantation. The solid organ
transplantation segment held the largest share of the transplant diagnostics
market in 2018 and is anticipated to hold the largest market size during the
forecast period.
Technology-Based
Insights
The global transplant diagnostics
market, based on technology, is segmented into molecular assays and
non-molecular assays. In 2018, the molecular assays systems segment held a
larger share of the market and is expected to witness growth in its demand at a
faster CAGR of 9.5% during 2019–2027.
Application-Based
Insights
The global transplant diagnostics
market, based on application, is segmented into diagnostic applications and
research applications. In 2018, the diagnostic applications segment held a
larger share and is expected to grow at a faster rate during the coming years.
Transplant
Diagnostics Market: Competitive Landscape and Key Developments
Bio-Rad Laboratories; Biomerieux SA;
Illumina SA; Thermo Fisher Scientific, Inc; Qiagen N.V; F. Hoffmann-La Roche
LTD.; Hologic Inc.; Luminex Corporation; Omixon Inc.; and Abbott are among the
leading companies in the transplant diagnostics market. The transplant diagnostics
market share is anticipated to flourish with the development of new innovative
products by market players.
- In April 2018, Qiagen
launched QIAstat-Dxâ in Europe. The product launched has played an
important role in oncology or transplantation surgeries, which improved
treatment decisions.
- In April 2017, One Lambda announced the availability of the FDA approved and CE marked LAB Screen Multi screening kit for detecting HNA-3 and HLA. Additional benefits of the product include processing up to 96 samples in under 4 hours.
Other Related
Reports:
About Us:
The Insight Partners is a one stop industry research
provider of actionable intelligence. We help our clients in getting solutions
to their research requirements through our syndicated and consulting research
services. We specialize in industries such as Semiconductor and Electronics,
Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare
IT, Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would
like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Comments
Post a Comment